{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:41:56Z","timestamp":1759405316135,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"28","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:00:00Z","timestamp":1684454400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.vaccine.2023.05.040","type":"journal-article","created":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T08:18:20Z","timestamp":1685002700000},"page":"4121-4128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A retrospective cohort study investigating the comparative effectiveness of pneumococcal vaccines against hospitalisation with otitis media and pneumonia in New Zealand"],"prefix":"10.1016","volume":"41","author":[{"given":"Janine","family":"Paynter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna S.","family":"Howe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Best","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Petousis-Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2023.05.040_b0005","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1086\/527396","article-title":"Protein D of Haemophilus influenzae: a protective nontypeable H. influenzae antigen and a carrier for pneumococcal conjugate vaccines","volume":"46","author":"Forsgren","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2023.05.040_b0010","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3201\/eid2801.210734","article-title":"Serotype replacement after introduction of 10-valent and 13-valent pneumococcal conjugate vaccines in 10 countries, Europe","volume":"28","author":"Hanquet","year":"2022","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2023.05.040_b0015","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1080\/21645515.2019.1612667","article-title":"A systematic literature review and network meta-analysis feasibility study to assess the comparative efficacy and comparative effectiveness of pneumococcal conjugate vaccines","volume":"15","author":"McGirr","year":"2019","journal-title":"Hum Vaccin Immunother"},{"year":"2014","series-title":"NZDep2013 index of deprivation","author":"Atkinson","key":"10.1016\/j.vaccine.2023.05.040_b0020"},{"issue":"6","key":"10.1016\/j.vaccine.2023.05.040_b0025","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/14760584.2018.1413354","article-title":"Public health impact of pneumococcal conjugate vaccine infant immunization programs: assessment of invasive pneumococcal disease burden and serotype distribution","volume":"17","author":"Izurieta","year":"2018","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"10.1016\/j.vaccine.2023.05.040_b0030","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1542\/peds.2003-0592-F","article-title":"Population-based impact of pneumococcal conjugate vaccine in young children","volume":"114","author":"Poehling","year":"2004","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.vaccine.2023.05.040_b0035","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.vaccine.2013.05.005","article-title":"Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects","volume":"32","author":"Davis","year":"2013","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2023.05.040_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-75691-5","article-title":"Divergent serotype replacement trends and increasing diversity in pneumococcal disease in high income settings reduce the benefit of expanding vaccine valency","volume":"10","author":"L\u00f8chen","year":"2020","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.vaccine.2023.05.040_b0045","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/14760584.2022.2012455","article-title":"A systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in children","volume":"21","author":"Mungall","year":"2022","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2023.05.040_b0050","article-title":"Pneumococcal conjugate vaccines for preventing acute otitis media in children","volume":"5","author":"Fortanier","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2023.05.040_b0055","article-title":"Pneumococcal conjugate vaccines for preventing acute otitis media in children","volume":"11","author":"de S\u00e9vaux","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2023.05.040_b0060","first-page":"1","article-title":"Systematic review of the efficacy, effectiveness and impact of high-valency pneumococcal conjugate vaccines on otitis media","author":"Izurieta","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2023.05.040_b0065","doi-asserted-by":"crossref","unstructured":"Gisselsson-Solen M. Trends in otitis media incidence after conjugate pneumococcal vaccination: a national observational study. 2017;36(11):1027-31.","DOI":"10.1097\/INF.0000000000001654"},{"issue":"2","key":"10.1016\/j.vaccine.2023.05.040_b0070","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1080\/21645515.2020.1775455","article-title":"The effect of pneumococcal conjugate vaccines on otitis media from 2005 to 2013 in children aged \u22645 years: a retrospective cohort study in two Swedish regions","volume":"17","author":"Edmondson-Jones","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2023.05.040_b0075","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ijporl.2016.05.011","article-title":"General health, otitis media, nasopharyngeal carriage and middle ear microbiology in Northern Territory Aboriginal children vaccinated during consecutive periods of 10-valent or 13-valent pneumococcal conjugate vaccines","volume":"86","author":"Leach","year":"2016","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"12","key":"10.1016\/j.vaccine.2023.05.040_b0080","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1080\/21645515.2020.1748978","article-title":"A longitudinal hospital-based epidemiology study to assess acute otitis media incidence and nasopharyngeal carriage in Korean children up to 24 months","volume":"16","author":"Lee","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2023.05.040_b0085","article-title":"Invasive Pneumococcal Disease in New Zealand, 2017\u20132019","author":"Anglemyer","year":"2021","journal-title":"Environ Sci Res"},{"issue":"5","key":"10.1016\/j.vaccine.2023.05.040_b0090","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/cid\/ciy570","article-title":"Pneumococcal conjugate vaccines turning the tide on inequity: a retrospective cohort study of New Zealand children born 2006\u20132015","volume":"68","author":"Petousis-Harris","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2023.05.040_b0095","unstructured":"ESR. Invasive Pneumococcal Disease Quarterly Report October\u2013December 2022. https:\/\/surv.esr.cri.nz\/PDF_surveillance\/IPD\/2022\/2022Q4_IPDReport.pdf."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23005911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23005911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:27:13Z","timestamp":1759404433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23005911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":19,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0264410X23005911"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.05.040","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A retrospective cohort study investigating the comparative effectiveness of pneumococcal vaccines against hospitalisation with otitis media and pneumonia in New Zealand","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.05.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}